Citadel Advisors - SPRINGWORKS THERAPEUTICS INC ownership

SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 141 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of SPRINGWORKS THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$663,683
-3.3%
28,706
+9.6%
0.00%
Q2 2023$686,466
-38.2%
26,181
-39.3%
0.00%
Q1 2023$1,110,758
-76.0%
43,153
-75.7%
0.00%
-100.0%
Q4 2022$4,623,173
-41.9%
177,746
-36.2%
0.00%
-50.0%
Q3 2022$7,955,000
+61.9%
278,795
+39.7%
0.00%
+100.0%
Q2 2022$4,914,000
-13.0%
199,615
+99.4%
0.00%0.0%
Q1 2022$5,649,000
+68.2%
100,099
+84.7%
0.00%0.0%
Q4 2021$3,358,000
-69.2%
54,182
-68.5%
0.00%
-50.0%
Q3 2021$10,920,000
-83.7%
172,136
-78.8%
0.00%
-86.7%
Q2 2021$66,919,000
+13.5%
812,025
+1.3%
0.02%
+7.1%
Q1 2021$58,958,000
+2.5%
801,391
+1.1%
0.01%
-6.7%
Q4 2020$57,493,000
+59.0%
792,786
+4.5%
0.02%
+50.0%
Q3 2020$36,161,000
-6.9%
758,579
-18.0%
0.01%
-28.6%
Q2 2020$38,837,000
+52.5%
924,681
-2.0%
0.01%
+27.3%
Q1 2020$25,469,000
-28.9%
943,295
+1.3%
0.01%
-31.2%
Q4 2019$35,829,000
+24.8%
930,869
-29.7%
0.02%
+14.3%
Q3 2019$28,700,0001,323,8170.01%
Other shareholders
SPRINGWORKS THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 3,081,307$71,239,8187.97%
Finepoint Capital LP 556,928$12,876,1756.41%
M28 Capital Management LP 197,700$4,570,8245.24%
Boxer Capital, LLC 3,421,541$79,106,0284.21%
Deep Track Capital, LP 3,546,435$81,993,5773.16%
EcoR1 Capital, LLC 3,460,208$80,000,0092.70%
Orbimed Advisors 3,968,588$91,753,7551.95%
Artal Group S.A. 1,816,620$42,0001.80%
SPHERA FUNDS MANAGEMENT LTD. 319,911$7,396,3421.35%
Perceptive Advisors 1,520,416$35,152,0171.17%
View complete list of SPRINGWORKS THERAPEUTICS INC shareholders